HSCS HeartSciences Inc.
Finance Services · Nasdaq · SEC CIK 1468492 · Fiscal year ends 04/30
Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-17.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin60.9%
Operating margin-209,733.1%
Net margin-227,024.2%
FCF margin—
EBITDA margin-209,135.3%
Returns
ROE-1,851.9%
ROA-201.7%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets154.4%
Debt / equity—
Current ratio0.14x
Interest coverage-11.78x
Cash quality & payout
Operating cash flow / net income0.66x
Accruals ratio-68.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-04-30 | FY20252025-04-30 |
|---|---|---|
| Income statement | ||
| Revenue | $4,319 | $4,350 |
| Cost of revenue | $1,768 | $1,880 |
| Gross profit | $2,551 | $2,470 |
| R&D expense | $2.84M | $4.39M |
| SG&A expense | $5.58M | $3.97M |
| Operating income | -$8.41M | -$8.35M |
| Interest expense | $753,041 | $500,453 |
| Income tax | $0 | $0 |
| Net income | -$9.14M | -$8.77M |
| EBITDA | -$8.39M | -$8.31M |
| EPS (basic) | -3.48 | -9.34 |
| EPS (diluted) | — | -9.34 |
| Dividends declared per share | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | — | 938,257 |
| Balance sheet | ||
| Cash & equivalents | $1.66M | $1.10M |
| Receivables | — | $4,350 |
| Inventory | $655,629 | $650,267 |
| Current assets | $2.58M | $2.17M |
| PP&E, net | $39,312 | $63,549 |
| Intangibles | $1.66M | $1.62M |
| Total assets | $5.26M | $4.22M |
| Current liabilities | $4.86M | $3.70M |
| Total liabilities | $5.04M | $4.02M |
| Shareholders' equity | $226,060 | $205,171 |
| Shares outstanding | 3.19M | 1.12M |
| Cash flow statement | ||
| Operating cash flow | -$7.43M | -$7.41M |
| Capital expenditure | $3,554 | $3,157 |
| Free cash flow | -$7.43M | -$7.42M |
| Investing cash flow | -$44,452 | -$30,188 |
| Financing cash flow | $8.03M | $2.73M |
| Depreciation & amortization | $27,791 | $37,599 |
| Stock-based compensation | $1.31M | $249,884 |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.